On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Fundacio Institut de Recerca Contra la Leucemia Josep Carreras's own share of each project, not the project's full budget.
- Horizon Europe€15.2M · 24 projects
- Horizon 2020€6.1M · 17 projects
- FP7 (2007 to 2013)€193k · 2 projects
Projects
43 EU-funded projects, newest first. Fundacio Institut de Recerca Contra la Leucemia Josep Carreras led 23 of them as coordinator. Each links to the official record.
- ProofReadingAssociated partner
European doctoral network for proofreading the proteome
Horizon Europe · 2027–2030 · Project on CORDIS ↗
- NAVIGATEAssociated partner
Next-generation AI and Computational Biology for Translational Excellence
Horizon Europe · 2026–2032 · Project on CORDIS ↗
- ACHILLESCoordinator
Advancing in the CHallenge of Improving Lymphoma and LEukemia Survival
Horizon Europe · 2025–2029 · Project on CORDIS ↗
€564ktheir share - MakingBloodPartner
Engineering an integrated platform for generation of human blood stem cells from pluripotent sources
Horizon Europe · 2025–2031 · Project on CORDIS ↗
€738ktheir share - BEMOSAICCoordinator
Decoding endothelial cell BEhavioral MOSAICism within single vessels
Horizon Europe · 2025–2031 · Project on CORDIS ↗
€3.5Mtheir share - NUCLEARCoordinator
METABOLIC REGULATION OF GENOME FUNCTION AND CELL IDENTITY
Horizon Europe · 2025–2029 · Project on CORDIS ↗
€504ktheir share - AdaptmetPartner
Deconstructing adaptive evolution of metastasis
Horizon Europe · 2025–2029 · Project on CORDIS ↗
€252ktheir share - CARLYCoordinator
Development and characterization of a novel CAR T-cell therapy for NHL
Horizon Europe · 2025–2027 · Project on CORDIS ↗
€226ktheir share - HubMOLPartner
Hub Molecules of Metabolism and Signalling – Key regulators of Life
Horizon Europe · 2025–2028 · Project on CORDIS ↗
€252ktheir share - IRB-TARGETAssociated partner
IRB Barcelona International PhD programme: on TARGET for high-impact biomedicine
Horizon Europe · 2024–2029 · Project on CORDIS ↗
- CarrerasPathfindersCoordinator
Enabling the next generation in search of blood cancer cures
Horizon Europe · 2024–2029 · Project on CORDIS ↗
€1.9Mtheir share - ChroMetCoordinator
Elucidating the role of macroH2A1.2 histone variant as a metabolic sensor in the epigenetic regulation of leukaemia cell fate.
Horizon Europe · 2024–2026 · Project on CORDIS ↗
€165ktheir share - FUN-HSCCoordinator
TACKLING FUNCTIONAL MATURATION FOR TRANSPLANTABLE HEMATOPOIETIC STEM CELL GENERATION
Horizon Europe · 2024–2028 · Project on CORDIS ↗
€2.1Mtheir share - IMMERGECoordinator
Storming Immune Monogenic Conditions through Multiomic and Gene Editing Approaches
Horizon Europe · 2024–2027 · Project on CORDIS ↗
€756ktheir share - THRIVEPartner
TUMOUR-HOST INTERACTIONS IN LIVER CANCER OF CHILDHOOD AND ADULTS
Horizon Europe · 2023–2028 · Project on CORDIS ↗
€690ktheir share - SIRT7-LCCoordinator
Role of the SIRT7-NPM-c-Myc pathway in lung cancer
Horizon Europe · 2023–2025 · Project on CORDIS ↗
€165ktheir share - ALERTCoordinator
Contribution of Lipid Droplets to the pathogenesis and chemoresistance of Acute Myeloid Leukemia
Horizon Europe · 2023–2026 · Project on CORDIS ↗
€226ktheir share - BiTE-CARCoordinator
CD22/CD19 dual redirection Dual targeting of CD22 and CD19 with BiTE-secreting and CAR-expressing bispecific T-cells for adoptive Cellular ImmunoTherapy in advanced B-cell Acute Lymphoblastic Leukemia
Horizon Europe · 2023–2025 · Project on CORDIS ↗
€150ktheir share - CARxALLAssociated partner
Next generation, off-the-shelf, non fratricide-directed, CAR immunotherapy for relapse/refractory T-cell acute lymphoblastic leukemia
Horizon Europe · 2023–2026 · Project on CORDIS ↗
- StemLincCoordinator
Identification and characterization of long non-coding RNAs as drivers of stemness in hematopoietic stem cells and leukemia.
Horizon Europe · 2023–2024 · Project on CORDIS ↗
€165ktheir share - CarrerasLeadersCoordinator
Carreras Postdoc Program Empowering Future Leaders to Fight Blood Cancers
Horizon Europe · 2023–2028 · Project on CORDIS ↗
€2.3Mtheir share - Maxima ButterflyAssociated partner
From Caterpillar to BUTTERFLY: supporting transformation of DCs in a paediatric oncology network
Horizon Europe · 2023–2027 · Project on CORDIS ↗
- SECUREDPartner
Scaling Up secure Processing, Anonymization and generation of Health Data for EU cross border collaborative research and Innovation
Horizon Europe · 2023–2025 · Project on CORDIS ↗
€230ktheir share - PROS-VARIANTCoordinator
PIK3CA-Related Overgrowth Spectrum: molecular mechanisms and preclinical modelling of PIK3CA VARIANTs
Horizon 2020 · 2022–2024 · Project on CORDIS ↗
€161ktheir share - CANCERNAPartner
RNA PROCESSING FOR ANTI-CANCER IMMUNOTHERAPY
Horizon Europe · 2022–2025 · Project on CORDIS ↗
€351ktheir share - SENAGECoordinator
Senescence as a key factor in leukemogenesis and bone marrow homeostasis in aging
Horizon 2020 · 2021–2023 · Project on CORDIS ↗
€173ktheir share - PIPgenCoordinator
PI3K/PTEN-related monogenic disease to understand cancer
Horizon 2020 · 2021–2025 · Project on CORDIS ↗
€502ktheir share - EvometPartner
Deconstructing the evolution of metastasis
Horizon 2020 · 2021–2025 · Project on CORDIS ↗
€502ktheir share - INTERCEPT-MDSCoordinator
Exploring cell-to-cell heterogeneity and exploiting epigenetic regulation for the interception of myeloid disease cells.
Horizon 2020 · 2021–2024 · Project on CORDIS ↗
€753ktheir share - IT4-TALLCoordinator
Clinical translation of a novel CD1a-directed CAR for relapse/refractory cortical T-cell Acute Lymphoblastic Leukemia: feasibility, efficacy and safety
Horizon 2020 · 2021–2022 · Project on CORDIS ↗
€150ktheir share - SirT-IMLEUCoordinator
Mechanisms of Sirtuin-dependent regulation of immunity and leukemogenesis
Horizon 2020 · 2020–2022 · Project on CORDIS ↗
€173ktheir share - HARMONY PLUSPartner
HEALTHCARE ALLIANCE FOR RESOURCEFUL MEDICINES OFFENSIVE AGAINST NEOPLASMS IN HEMATOLOGY – PLUS
Horizon 2020 · 2020–2024 · Project on CORDIS ↗
€90ktheir share - €110ktheir share
- HifLICsCoordinator
Acute Myeloid Leukemia Leukemic Initiating Cells: Contribution of hypoxia/HIF pathway to chemoresistance and relapse
Horizon 2020 · 2019–2020 · Project on CORDIS ↗
€158ktheir share - IT4B-ALLCoordinator
Therapeutic immunotherapy targeting NG2 and CD22 antigens for MLL-rearranged and MLL-germline B-cell Acute Lymphoblastic Leukemia
Horizon 2020 · 2019–2020 · Project on CORDIS ↗
€150ktheir share - CLOSERPartner
Childhood Leukemia: Overcoming distance between South America and Europe Regions
Horizon 2020 · 2019–2024 · Project on CORDIS ↗
€151ktheir share - InTheMLLrBALLCoordinator
Innovative Therapeutic Strategies for Mixed Lineage Leukemia-rearranged B-cell Acute Lymphoblastic Leukemia
Horizon 2020 · 2018–2020 · Project on CORDIS ↗
€158ktheir share - HARMONYPartner
Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026
Horizon 2020 · 2017–2023 · Project on CORDIS ↗
€153ktheir share - ChroMePartner
Chromatin and Metabolism Chromatin-metabolism interactions as targets for healthy living
Horizon 2020 · 2016–2020 · Project on CORDIS ↗
€496ktheir share - INFANTLEUKEMIACoordinator
GENOMIC, CELLULAR AND DEVELOPMENTAL RECONSTRUCTION OF INFANT MLL-AF4+ ACUTE LYMPHOBLASTIC LEUKEMIA
Horizon 2020 · 2016–2021 · Project on CORDIS ↗
€2.0Mtheir share
Show 3 more projects
- RELEVANCEPartner
Regulation of red cell life-span, erythropoiesis, survival, senescence and clearance
Horizon 2020 · 2015–2019 · Project on CORDIS ↗
€238ktheir share - MODELING MLL-AF4 ALLPartner
Cell of origin/Leukemia Initiating Cell in infant Pro-B MLL-AF4+ ALL
FP7 (2007 to 2013) · 2014–2018 · Project on CORDIS ↗
€63ktheir share - COMMITMENTPartner
Combined Molecular Microscopy for Therapy and Personalized Medication in Rare Anaemias Treatments
FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗
€130ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Erasmus Universitair Medisch Centrum RotterdamNetherlands · 7 shared projects
- University of Newcastle Upon TyneUnited Kingdom · 7 shared projects
- Onechain Immunotherapeutics S.l.Spain · 7 shared projects
- The Chancellor Masters and Scholars of the University of CambridgeUnited Kingdom · 6 shared projects
- Ludwig-Maximilians-Universitaet MuenchenGermany · 6 shared projects
- Stichting Amsterdam UmcNetherlands · 6 shared projects
- Universitat de BarcelonaSpain · 6 shared projects
- Fundacio de Recerca Clinic Barcelona-Institut D Investigacions Biomediques August Pi i SunyerSpain · 6 shared projects
- Scienseed SLSpain · 6 shared projects
- Charite - Universitaetsmedizin BerlinGermany · 5 shared projects
- Deutsches Krebsforschungszentrum HeidelbergGermany · 5 shared projects
- Fundacio Institut de Recerca Biomedica (Irb Barcelona)Spain · 5 shared projects
- European Hematology AssociationNetherlands · 5 shared projects
- Mll Munchner Leukamielabor GmbHGermany · 5 shared projects
- Institut National de la Sante et de la Recherche MedicaleFrance · 4 shared projects
- Helsingin YliopistoFinland · 4 shared projects
Fields it works in
Research fields recorded on its Horizon projects.
- DNA
- RNA
- artificial intelligence
- big data
- biochemistry
- bioreactors
- cell biology
- cell signaling
- cells technologies
- civil society
- composites
- databases
- diabetes
- drug discovery
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗
